Aequitas Research - Frasers Logistics Industri (FLT) Frasers Logistics Placement - Consistent Performance, Accretive Deal

Report

Aequitas Research

Zhen Zhou Toh

EUR 93.06 For Business Accounts Only

Frasers Logistics Placement - Consistent Performance, Accretive Deal

Frasers Logistics & Commercial (FLT SP) is raising US$231m to partially fund its acquisition of logistics and industrial properties in Germany, the Netherlands and, UK. This is the first placement that the REIT is conducting since its merger with FCOT.

We have covered the REIT's previous placement and IPO in:

Frasers Logistics Placement - Acquisition Executed As Guided with Good Track Record
Frasers Logistics Placement - Well Flagged, Accretive Acquisition that Diversifies Portfolio
Frasers Logistics IPO - Reasonable Valuation but Decade Low Cap Rates Remain a Worry

24/05/2021 7 EN

Underlying

Frasers Logistics & Industri

See profile

Provider

Aequitas Research

Aequitas Research is a leading ECM research firm with a focus on IPOs and placements/follow-on offerings across the Asia Pacific with deal size of over USD100m.

Since 2015, we have covered 400+ IPOs and 450+ placements with a hit rate of 73% and 65%, respectively. We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic analysis.

Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis. We also provide a more quant driven analysis on placement/follow-on offerings.

Markets that we cover include:
Hong Kong,
China ADRs,
India,
Japan,
Australia, and
ASEAN.

See profile

Analysts

Zhen Zhou Toh

Other Reports on these Companies

UOB

REITs - S-REITs bi-weekly updates (16-26 Feb 21)

S-REITs corrected 2.4% during 16-26 Feb. We expect the rise in the bond yield to persist in the near term, which puts pressure on blue chip S-REITs which are well owned by institutional investors. Switch to laggard S-REITs sheltered from the higher bond yield with their much higher yields. BUY ALLT (Target: S$0.89), LREIT (Target: S$0.97), SUN (Target: S$1.72) and UHU (Target: US$0.95), which provide distribution yields of 7%, 6.2%, 6.5% and 9.4% respectively. Maintain OVERWEIGHT.

March 3, 2021 March 3, 2021 1 EN

UOB

REITs - Bi-weekly update (16-31 Dec 20)

S-REITs gained 1.4% during 16-31 Dec 20. The slew of acquisitions and divestments continued unabated as we approached the year-end. Switch to recovery plays and laggards. BUY AREIT (Target: S$3.68), FCT (Target: S$3.15), LREIT (Target: S$0.97), FEHT (Target: S$0.74) and SUN (Target: S$1.75), which provide distribution yields of 5.1%, 5.6%, 6.6%, 4.5% and 6.4% respectively. Maintain OVERWEIGHT.

January 5, 2021 January 5, 2021 1 EN

Onewo Space-Tech Pre-IPO

Onewo Space-Tech (OST) aims to raise around US$2bn in its Hong Kong IPO. OST is a property management service provider in China, primarily owned by China Vanke. As per Frost & Sullivan, in 2020, amongst the residential community service providers in the market, OST ranked first in terms of revenue. It also ranked first in the commercial space integrated services market in China. As of end FY21, it has a footprint in 153 cities in 32 provinces across China with 89% of total GFA under management for residential properties located in first-tier, new first-tier and second-tier cities. OST has m...

EUR 93.06

July 27, 2022 July 27, 2022 1 EN

Sumeet Singh

Sumeet Singh

Legend Biotech Follow-on Offering

Legend Biotech, a non-wholly owned subsidiary of Hong Kong-listed GenScript, is planning to raise up to US$250m in its follow-on offering. The company last raised cash in Dec 2021 in a similar sized deal, which ended up doing very well after a sharp share price correction. In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

EUR 93.06

July 26, 2022 July 26, 2022 1 EN

Clarence Chu

Clarence Chu

Xtep International Placement

Group Success Investments is looking to raise up to US$133m by trimming its holdings in Xtep International. We can’t say that the deal is expected and short interest on the stock hasn’t been creeping up as well. While the deal won’t be a large one, representing just 5.7 days of three month ADV, the firm’s last deal hasn’t done well.

EUR 93.06

July 26, 2022 July 26, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Frasers Logistics Placement - Consistent Performance, Accretive Deal

REITs - S-REITs bi-weekly updates (16-26 Feb 21)

REITs - Bi-weekly update (16-31 Dec 20)

Onewo Space-Tech Pre-IPO

Legend Biotech Follow-on Offering

Xtep International Placement

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe